ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study.

ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study.

<p><strong>INTRODUCTION:</strong> In this study (PRECISE), we assess the clinical utility of a germline DNA sequencing-based test (ToxNav) for mutations in DPYD and ENOSF1 genes to alter clinician-prescribed fluoropyrimidine doses and the use of a digital application (PROMinet) to...

Повний опис

Бібліографічні деталі
Автори: Lee, L, Starkey, T, Sivakumar, S, Fotheringham, S, Mozolowski, G, Shearwood, V, Palles, C, Camilleri, P, Church, D, Kerr, R, Kerr, D
Формат: Conference item
Опубліковано: Wiley 2019

Схожі ресурси

Схожі ресурси